Streetbeat News

Regulatory

CELZ

Creative Medical Technologies has filed four new patent applications covering a range of medical treatments using regenerative cells and adjuvants. These applications focus on reproductive failure, orthopox viruses, space travel-associated bone density loss, and hair loss prevention and treatment.

Portfolio Pulse from Charles Gross

March 07, 2024 | 2:49 pm

CODX

Co-Diagnostics, Inc.'s joint venture, CoSara, has received regulatory clearance from Indian authorities for its Influenza Multiplex PCR Test. This approval allows CoSara to market and distribute the test in India, potentially expanding Co-Diagnostics' market presence and revenue streams in the region.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:31 pm

JVA

Coffee Holding Co., Inc. (NASDAQ:JVA) and Delta Corp Holdings Limited announced the SEC's approval of their proposed business combination's registration statement. A special meeting for Coffee Holding's stockholders is scheduled for March 28, 2024, to vote on the merger, which would result in both companies becoming subsidiaries of a new Cayman Islands-based holding company. Coffee Holding's board unanimously recommends approval of the merger.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:25 pm

CYCC

CYCCP

Cyclacel Pharmaceuticals, Inc. announced that preclinical proof-of-concept data for its drug fadraciclib will be presented at the AACR Annual Meeting 2024. The data demonstrates fadraciclib's activity and antitumor effects in various cancers. Fadraciclib, a CDK2/9 inhibitor, has shown promising results in early trials for multiple cancer types. The company is currently conducting a Phase 1/2 trial for fadraciclib in advanced solid tumors and lymphoma.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:24 pm

CELZ

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced FDA authorization for CELZ-201, a cell-based therapy aimed at preventing Type 1 Diabetes Mellitus (T1D) in high-risk individuals. This marks a significant advancement in T1D prevention, showcasing CELZ's commitment to innovative healthcare solutions.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:23 pm

OND

SOCL

SPOT

Spotify Technology SA (NYSE:SPOT) is raising its subscription fees in France in response to a new 1.2% music tax effective January 1, aimed at supporting the national music sector. This move comes after Spotify's criticism of the tax, which also affects other music streaming services like Apple Music and Google's YouTube Music. Despite a revenue increase in Q4, Spotify's earnings were below consensus. The company's strategy includes price adjustments rather than exiting the French market. Investors can access Spotify through Global X Social Media ETF (NASDAQ:SOCL) and ProShares On-Demand ETF (NYSE:OND).

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 2:18 pm

AMGN

AZN

BMY

JNJ

LLY

MRK

NVS

President Joe Biden is proposing to increase the number of prescription drugs subject to Medicare negotiation from 20 to 50 annually by 2029, aiming to reduce medication costs for seniors. This expansion is part of a broader initiative to cut federal spending by $200 billion and includes capping Medicare copayments and extending out-of-pocket cost caps. The pharmaceutical industry is expected to oppose this move, which could significantly impact their profits.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 2:15 pm

NUWE

Nuwellis announced results from two new clinical data analyses from the AVOID-HF trial, showing the benefits of the Aquadex system for heart failure. The analyses demonstrated that ultrafiltration therapy is statistically superior to intravenous loop diuretics in reducing heart failure events and hospitalizations. Additionally, an AI and machine learning-based model indicated that lifestyle and clinical factors are strong predictors of heart failure events.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:10 pm

SEDG

SolarEdge Technologies, Inc. (NASDAQ:SEDG) has announced an investment and partnership with AMPEERS ENERGY, a German software start-up focused on decarbonizing multi-dwelling buildings. This collaboration aims to combine SolarEdge's solar and smart energy technology with AMPEERS's platform to offer a comprehensive photovoltaic tenant electricity solution for real estate companies. The solution includes planning, implementation, and financing of solar and storage generation, tenant electricity billing, EV charging, and new heating technologies. This strategic move is designed to capitalize on legislative changes in Germany and expand into the multi-dwelling market across Europe.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:04 pm

MULN

Mullen Automotive, Inc. has regained compliance with Nasdaq's listing requirements, ensuring its continued listing on the exchange. This development is significant for the company and its investors, as it reflects positively on Mullen's operational and financial adjustments aimed at meeting Nasdaq's standards.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:04 pm